000 01508 a2200421 4500
005 20250513090546.0
264 0 _c19960627
008 199606s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19950801)76:3<535::aid-cncr2820760331>3.0.co;2-k
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFedele, P
245 0 0 _aOndansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
_h[electronic resource]
260 _bCancer
_cAug 1995
300 _a535-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comment; Comparative Study; Letter; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntiemetics
_xadverse effects
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aGranisetron
_xadverse effects
650 0 4 _aHumans
650 0 4 _aLymphoma, AIDS-Related
_xdrug therapy
650 0 4 _aLymphoma, Non-Hodgkin
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aNausea
_xchemically induced
650 0 4 _aOndansetron
_xadverse effects
650 0 4 _aProspective Studies
650 0 4 _aVomiting
_xchemically induced
700 1 _aSpina, M
700 1 _aValentini, M
700 1 _aCollini, D
700 1 _aLucia, C
700 1 _aManicone, M
700 1 _aTirelli, U
773 0 _tCancer
_gvol. 76
_gno. 3
_gp. 535-6
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19950801)76:3<535::aid-cncr2820760331>3.0.co;2-k
_zAvailable from publisher's website
999 _c8624187
_d8624187